Cronos Group Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Cronos Group wird ein jährliches Gewinn- und Umsatzwachstum von 8.3% bzw. 4.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich sinken um 1.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich -7.8% betragen.

Wichtige Informationen

8.3%

Wachstumsrate der Gewinne

-1.4%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum	53.4%
Wachstumsrate der Einnahmen	4.9%
Zukünftige Eigenkapitalrendite	-7.8%
Analystenabdeckung	Good
Zuletzt aktualisiert	13 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

We're Interested To See How Cronos Group (TSE:CRON) Uses Its Cash Hoard To Grow

May 31

Cronos Group Inc.'s (TSE:CRON) P/S Is Still On The Mark Following 29% Share Price Bounce

Apr 01

Cronos Group Inc.'s (TSE:CRON) Earnings Haven't Escaped The Attention Of Investors

Jun 20

We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Feb 09

A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)

Oct 12

We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate

Sep 10

Cronos Group Inc. (TSE:CRON) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Aug 12

We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

May 19

Is Cronos Group Inc. (TSE:CRON) Trading At A 47% Discount?

Jul 29

An Intrinsic Calculation For Cronos Group Inc. (TSE:CRON) Suggests It's 29% Undervalued

Apr 08

Have Insiders Sold Cronos Group Inc. (TSE:CRON) Shares Recently?

Mar 04

Gewinn- und Umsatzwachstumsprognosen

TSX:CRON - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	126	-24	N/A	17	2
12/31/2025	133	-11	4	12	4
12/31/2024	113	-29	-3	23	6
9/30/2024	111	-48	17	28	N/A
6/30/2024	102	-57	11	16	N/A
3/31/2024	93	-54	-2	3	N/A
12/31/2023	87	-70	-46	-43	N/A
9/30/2023	85	-101	-86	-84	N/A
6/30/2023	81	-133	-101	-97	N/A
3/31/2023	84	-145	-108	-103	N/A
12/31/2022	87	-155	-94	-89	N/A
9/30/2022	91	-213	-105	-101	N/A
6/30/2022	91	-102	-124	-119	N/A
3/31/2022	85	-263	-147	-141	N/A
12/31/2021	65	-127	-166	-154	N/A
9/30/2021	66	-373	-179	-156	N/A
6/30/2021	57	-381	-181	-153	N/A
3/31/2021	51	-310	-188	-153	N/A
12/31/2020	47	-72	-180	-145	N/A
9/30/2020	37	101	-185	-160	N/A
6/30/2020	31	636	-186	-152	N/A
3/31/2020	29	929	-192	-155	N/A
12/31/2019	24	1,167	-170	-131	N/A
9/30/2019	21	1,089	-131	-59	N/A
6/30/2019	18	479	-130	-49	N/A
3/31/2019	13	293	-104	-11	N/A
12/31/2018	12	-21	-96	-8	N/A
9/30/2018	9	-8	-103	-28	N/A
6/30/2018	7	-1	N/A	-16	N/A
3/31/2018	5	-2	N/A	-13	N/A
12/31/2017	3	-1	N/A	-4	N/A
9/30/2017	4	1	N/A	-4	N/A
6/30/2017	2	0	N/A	-8	N/A
3/31/2017	1	-1	N/A	-6	N/A
12/31/2016	0	-1	N/A	-5	N/A
9/30/2016	2	0	N/A	-3	N/A
6/30/2016	2	0	N/A	-2	N/A
3/31/2016	3	1	N/A	-1	N/A
12/31/2015	2	0	N/A	-1	N/A
9/30/2015	0	-4	N/A	-2	N/A
6/30/2015	-1	-4	N/A	-2	N/A
3/31/2015	-1	-4	N/A	-2	N/A
12/31/2014	-1	-4	N/A	-1	N/A
9/30/2014	0	-2	N/A	-1	N/A
6/30/2014	0	-1	N/A	-1	N/A
12/31/2013	0	-1	N/A	0	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CRON wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: CRON wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: CRON wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: CRONDie Einnahmen des Unternehmens (4.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Canadian (7.1% pro Jahr).

Hohe Wachstumseinnahmen: CRONDie Einnahmen des Unternehmens (4.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: CRON wird voraussichtlich in 3 Jahren unrentabel sein.

Cronos Group Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus revenue estimates increase by 12%, EPS downgraded

Consensus EPS estimates upgraded to US$0.074 loss

No longer forecast to breakeven

Consensus EPS estimates fall by 10%

No longer forecast to breakeven

Consensus EPS estimates fall by 93%

Recent updates

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Consensus revenue estimates increase by 12%, EPS downgraded

Consensus EPS estimates upgraded to US$0.074 loss

Cronos Group Inc. Announces Lord Jones Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada

No longer forecast to breakeven

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 10%

No longer forecast to breakeven

Consensus EPS estimates fall by 93%

Cronos Group Inc. Brand Spinach®? Celebrates Summer with New Launches

Cronos Group Inc. Elects Murray Garnick as Director

We're Interested To See How Cronos Group (TSE:CRON) Uses Its Cash Hoard To Grow

Forecast breakeven date moved forward to 2025

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates upgraded to US$0.036 loss

No longer forecast to breakeven

Consensus EPS estimates fall by 24%

Cronos Group Inc.'s (TSE:CRON) P/S Is Still On The Mark Following 29% Share Price Bounce

Cronos Group Inc., Annual General Meeting, Jun 20, 2024

Consensus EPS estimates upgraded to US$0.037 loss

Cronos Group Inc. Launches Lord Jones Chocolate Fusions

President exercised options and sold CA$232k worth of stock

Full year 2023 earnings: EPS and revenues miss analyst expectations

We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Consensus EPS estimates fall by 44%

Revenues Tell The Story For Cronos Group Inc. (TSE:CRON)

Forecast to breakeven in 2026

President exercised options and sold CA$169k worth of stock

Cronos Group Inc. Announces Launch of Its Highly Anticipated Lord Jones Live Resin Vapes in Two Different Hardware Options

Future Farmco Canada Inc. entered into an agreement to acquire Peace Naturals Project Inc. from Cronos Group Inc. (TSX:CRON) for CAD 23 million.

Future Farmco Canada Inc. entered into an agreement to acquire Peace Naturals Project Inc. from Cronos Group Inc. (TSX:CRON) for CAD 23 million.

Forecast to breakeven in 2025

Third quarter 2023 earnings released: US$0.005 loss per share (vs US$0.098 loss in 3Q 2022)

Companies Like Cronos Group (TSE:CRON) Are In A Position To Invest In Growth

Cronos Group Inc. Launches Its Cannabis Brand Lord Jones in the Canadian Adult-Use Cannabis Market

Cronos Group Inc. Unveils Its New THCV Products: Spinach FEELZ™? Full Tilt

Consensus revenue estimates decrease by 14%, EPS upgraded

Cronos Group Inc. Revises Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

We're Hopeful That Cronos Group (TSE:CRON) Will Use Its Cash Wisely

Cronos Reportedly Explores Possible Sale After Attracting Takeover Interest

Cronos Group Inc.'s (TSE:CRON) Earnings Haven't Escaped The Attention Of Investors

Cronos Group Inc. Announces Executive Changes

President exercised options and sold CA$63k worth of stock

Consensus EPS estimates upgraded to US$0.14 loss, revenue downgraded

Price target decreased by 8.6% to CA$3.78

Cronos Group Inc. Provides Revenue Guidance for the Full Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus revenue estimates decrease by 11%, EPS upgraded

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased by 11% to CA$4.58

We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Insufficient new directors

Cronos Unveils Its New CBC Product: Spinach FEELZ™ Day Trip Gummies with THC+CBC

Cronos Group Inc Announces Executive Changes

Cronos Group Inc. Announces Final Settlement Agreements with U.S. Securities and Exchange Commission and the Staff of the Ontario Securities Commission

Cronos Group Inc. Announces Executive Changes

A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)

Insufficient new directors

We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate

President exercised options and sold CA$58k worth of stock

Independent Director exercised options and sold CA$654k worth of stock

Insider exercised options and sold CA$301k worth of stock

Cronos Group Inc. (TSE:CRON) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Second quarter 2022 earnings: Revenues miss analyst expectations

Consensus forecasts updated

We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth

Cronos Group Inc., Annual General Meeting, Jun 23, 2022

Cronos Group Inc., Annual General Meeting, Jun 23, 2022